These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10518361)

  • 1. Biochemical markers for assessment of bone metastases in patients with breast cancer.
    Hou MF; Tsai LY; Tsai SM; Huang CJ; Huang YS; Hsieh JS; Chan HM; Wang JY; Chuang CH; Chen FM; Huang TJ
    Kaohsiung J Med Sci; 1999 Aug; 15(8):452-60. PubMed ID: 10518361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of urine deoxypyridinoline for detecting bone metastases in breast cancer patients.
    Hou MF; Lin SB; Yuan SS; Tsai LY; Tsai SM; Hsieh JS; Huang TJ
    Ann Clin Lab Sci; 2003; 33(1):55-61. PubMed ID: 12661898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The course of the urinary DPD-crosslink secretion in metastatic breast cancer--a possibility for response assessment.
    Lüftner D; Günther S; Flath B; Müller C; Echteroff K; Mergenthaler HG; Wernecke KD; Possinger K
    Anticancer Res; 1999; 19(4A):2537-44. PubMed ID: 10470191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of bone markers for detection of bone metastases in lung cancer patients.
    Alataş F; Alataş O; Metintaş M; Colak O; Erginel S; Harmanci E
    Clin Biochem; 2002 Jun; 35(4):293-6. PubMed ID: 12135691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
    Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
    J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.
    Seibel MJ; Woitge HW; Pecherstorfer M; Karmatschek M; Horn E; Ludwig H; Armbruster FP; Ziegler R
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3289-94. PubMed ID: 8784085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report.
    Shimozuma K; Sonoo H; Fukunaga M; Ichihara K; Aoyama T; Tanaka K
    Jpn J Clin Oncol; 1999 Jan; 29(1):16-22. PubMed ID: 10073146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease.
    Pecherstorfer M; Zimmer-Roth I; Schilling T; Woitge HW; Schmidt H; Baumgartner G; Thiébaud D; Ludwig H; Seibel MJ
    J Clin Endocrinol Metab; 1995 Jan; 80(1):97-103. PubMed ID: 7829646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer.
    Chung JH; Park MS; Kim YS; Chang J; Kim JH; Kim SK; Kim SK
    Yonsei Med J; 2005 Jun; 46(3):388-93. PubMed ID: 15988811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
    Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine calcium and deoxypyridinoline in assessment of response to local radiation therapy for metastatic bone disease.
    Topkan E; Karaoglu A
    J Exp Clin Cancer Res; 2007 Dec; 26(4):553-9. PubMed ID: 18365552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of two serum isoenzyme phosphatases as bone metastasis markers].
    Desoize B; Pourny C; Amico S; Larbre H; Jardillier JC
    Bull Cancer; 1990; 77(12):1211-21. PubMed ID: 2081281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of biochemical indices as metastatic markers in patients with prostatic cancer invading skeleton].
    Liubimova NV; Trapeznikova MF; Robins SP; Ognerubov SA; Kushlinskiĭ NE
    Urologiia; 2000; (4):15-9. PubMed ID: 11186686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
    Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A
    Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment levels of urinary deoxypyridinoline as a potential marker in patients with prostate cancer with or without bone metastasis.
    Wymenga LF; Groenier K; Schuurman J; Boomsma JH; Elferink RO; Mensink HJ
    BJU Int; 2001 Aug; 88(3):231-5. PubMed ID: 11488735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases.
    Voorzanger-Rousselot N; Journe F; Doriath V; Body JJ; Garnero P
    Calcif Tissue Int; 2009 May; 84(5):348-54. PubMed ID: 19252761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
    Leder BZ; Smith MR; Fallon MA; Lee ML; Finkelstein JS
    J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.